Succinyl-CoA:3-ketoacid CoA transferase deficiency
Ultimo aggiornamento 19 Apr 2021
Rispetta le linee guida editoriali
- ScaricaScarica
- Condividi
- Language
- Discussione
- Ask Patient
- Versione audio
- Aggiungi alle fonti preferite su Google
Succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency is an inherited disorder that impairs the body's ability to break down ketones, which are molecules produced in the liver during the breakdown of fats.
Scelte video per Condizioni geneticheVideo library
Descrizione
Succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency is an inherited disorder that impairs the body's ability to break down ketones, which are molecules produced in the liver during the breakdown of fats.
The signs and symptoms of SCOT deficiency typically appear within the first few years of life. Affected individuals experience episodes of extreme tiredness (lethargy), appetite loss, vomiting, rapid breathing, and, occasionally, seizures. These episodes, which are called ketoacidotic attacks, sometimes lead to coma. About half of affected individuals have a ketoacidotic attack within the first 4 days of life. Affected individuals have no symptoms of the disorder between ketoacidotic attacks.
People with SCOT deficiency usually have a permanently elevated level of ketones in their blood (persistent ketosis). If the level of ketones gets too high, which can be brought on by infections, fevers, or periods without food (fasting), a ketoacidotic attack can occur. The frequency of ketoacidotic attacks varies among affected individuals.
Modelli di ereditarietà
The source lists the following possible inheritance patterns: Autosomal recessive. More than one pattern can apply in different cases.
Related genes
Altri nomi
3-oxoacid CoA transferase deficiency
Ketoacidosis due to SCOT deficiency
SCOT deficiency
Succinyl-CoA 3-oxoacid transferase deficiency
Succinyl-CoA:3-oxoacid CoA transferase deficiency
Succinyl-CoA:acetoacetate transferase deficiency
Related patient information and medicines

Patient information leaflet
Test di funzionalità epatica
What are the main liver function tests. The usual liver function tests typically include the following: Bilirubin. Albumin. Total protein. Transferasi (AST o SGOT e ALT o SGPT). Gamma GT. Creatine kinase. These woul... Almost any pattern of liver function test abnormality can be caused by medicines (including over-the-counter medications), by.

Patient information leaflet
Macrocitosi e anemia macrocitica
Macrocytosis refers to red blood cells which are larger than normal. It does not cause any symptoms in itself. Macrocytosis symptoms You may also find relevant information in our other separate leaflet called What is blood. What is blood. Macrocytosis can exist without anaemia. Macrocytosis itself does not cause any symptoms but can be a sign of.

Patient information leaflet
Posso prendere Ashwagandha e acido folico insieme?
It is advisable to take your folic acid supplement at a different tim... Using other medicines Taking multiple medicines. Our Controllo Interazioni Farmaci helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Simply search for your medicines to see potential interactions and what to do.

Patient information leaflet
Posso assumere acido folico e vitamina C insieme?
There is no harmful interaction between folic acid and vitamin C. In fact, taking them together is generally considered beneficial. Vitamin C can help prevent the breakdown of folic acid in the stomach, potentially making it easier for your body to use. Why this happens Vitamin C (ascorbic acid) acts as an antioxidant that helps stabilise folate.

Patient information leaflet
Sindrome da refeeding
Refeeding syndrome was first described in Far East prisoners after the second world war when they developed heart failure after starting to eat again after a prolonged period of starvation. What is refeeding syndrome. Refeeding syndrome is a dangerous and life threatening shift of fluids and body salts (electrolytes) that can occur when.

Patient information leaflet
Posso prendere Carbocisteina e Omega-3 insieme?
Omega-3 fatty acids are nutrients used by the body for various functions, including heart and brain health. Using othe... Our Controllo Interazioni Farmaci helps you check whether your prescriptions, over-the-counter medicines, and supplements are safe to take together. Simply search for your medicines to see potential interactions and what to do.
Ulteriori letture e riferimenti
- Succinyl-CoA:3-ketoacid CoA transferase deficiency; MedlinePlus, National Library of Medicine.
- Berry GT, Fukao T, Mitchell GA, Mazur A, Ciafre M, Gibson J, Kondo N, Palmieri MJ. Neonatal hypoglycaemia in severe succinyl-CoA: 3-oxoacid CoA-transferase deficiency. J Inherit Metab Dis. 2001 Oct;24(5):587-95. doi: 10.1023/a:1012419911789.
- Fukao T, Ishii T, Amano N, Kursula P, Takayanagi M, Murase K, Sakaguchi N, Kondo N, Hasegawa T. A neonatal-onset succinyl-CoA:3-ketoacid CoA transferase (SCOT)-deficient patient with T435N and c.658-666dupAACGTGATT p.N220_I222dup mutations in the OXCT1 gene. J Inherit Metab Dis. 2010 Dec;33 Suppl 3:S307-13. doi: 10.1007/s10545-010-9168-5. Epub 2010 Jul 21.
- Fukao T, Mitchell GA, Song XQ, Nakamura H, Kassovska-Bratinova S, Orii KE, Wraith JE, Besley G, Wanders RJ, Niezen-Koning KE, Berry GT, Palmieri M, Kondo N. Succinyl-CoA:3-ketoacid CoA transferase (SCOT): cloning of the human SCOT gene, tertiary structural modeling of the human SCOT monomer, and characterization of three pathogenic mutations. Genomics. 2000 Sep 1;68(2):144-51. doi: 10.1006/geno.2000.6282.
- Fukao T, Sass JO, Kursula P, Thimm E, Wendel U, Ficicioglu C, Monastiri K, Guffon N, Baric I, Zabot MT, Kondo N. Clinical and molecular characterization of five patients with succinyl-CoA:3-ketoacid CoA transferase (SCOT) deficiency. Biochim Biophys Acta. 2011 May;1812(5):619-24. doi: 10.1016/j.bbadis.2011.01.015. Epub 2011 Feb 2.
- Fukao T, Shintaku H, Kusubae R, Zhang GX, Nakamura K, Kondo M, Kondo N. Patients homozygous for the T435N mutation of succinyl-CoA:3-ketoacid CoA Transferase (SCOT) do not show permanent ketosis. Pediatr Res. 2004 Dec;56(6):858-63. doi: 10.1203/01.PDR.0000145297.90577.67. Epub 2004 Oct 20.
Condividi i tuoi pensieri o esperienze con gli altri nel nostro comunità di pazienti.
Iscriviti alla newsletter di Patient
La tua dose settimanale di consigli sulla salute chiari e affidabili - scritti per aiutarti a sentirti informato, sicuro e in controllo.
Abbonandoti accetti i nostri Informativa sulla Privacy. Puoi annullare l'iscrizione in qualsiasi momento. Non vendiamo mai i tuoi dati.

